{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T12:52:52Z","timestamp":1789735972091,"version":"4.0.1"},"reference-count":65,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004731","name":"Zhejiang Province Natural Science Foundation","doi-asserted-by":"publisher","award":["LGF22H180023"],"award-info":[{"award-number":["LGF22H180023"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.ejpb.2024.114351","type":"journal-article","created":{"date-parts":[[2024,6,7]],"date-time":"2024-06-07T00:23:02Z","timestamp":1717719782000},"page":"114351","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Nanoparticle-hydrogel composite as dual-drug delivery system for the potential application of corneal graft rejection"],"prefix":"10.1016","volume":"201","author":[{"given":"Xiaoning","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuqin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruiling","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-4551-6672","authenticated-orcid":false,"given":"Zhaoliang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangyi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhan","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0368-4538","authenticated-orcid":false,"given":"Xingyi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7602-7910","authenticated-orcid":false,"given":"Deqing","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhishu","family":"Bao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejpb.2024.114351_b0005","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/j.survophthal.2016.12.010","article-title":"Management of high-risk corneal transplantation","volume":"62","author":"Di Zazzo","year":"2017","journal-title":"Surv. Ophthalmol."},{"key":"10.1016\/j.ejpb.2024.114351_b0010","article-title":"Corneal allograft rejection: immunopathogenesis to therapeutics","volume":"2013","author":"Qazi","year":"2013","journal-title":"J. Clin. Cell Immunol."},{"key":"10.1016\/j.ejpb.2024.114351_b0015","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1136\/bjo.2006.097428","article-title":"Tacrolimus immunosuppression in high-risk corneal grafts","volume":"91","author":"Joseph","year":"2007","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.ejpb.2024.114351_b0020","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1038\/sj.eye.6700634","article-title":"Management of high-risk corneal grafts","volume":"17","author":"Coster","year":"2003","journal-title":"Eye"},{"key":"10.1016\/j.ejpb.2024.114351_b0025","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1097\/ACI.0b013e32833dfa11","article-title":"High risk corneal allografts and why they lose their immune privilege","volume":"10","author":"Niederkorn","year":"2010","journal-title":"Curr. Opin. Allergy Clin. Immunol."},{"key":"10.1016\/j.ejpb.2024.114351_b0030","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1097\/00003226-200308000-00013","article-title":"Long-term outcome in high-risk corneal transplantation and the influence of HLA-A and HLA-B matching","volume":"22","author":"Bartels","year":"2003","journal-title":"Cornea"},{"key":"10.1016\/j.ejpb.2024.114351_b0035","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.survophthal.2020.10.003","article-title":"Corneal transplantation after failed grafts: Options and outcomes","volume":"66","author":"Del Barrio","year":"2021","journal-title":"Surv. Ophthalmol."},{"key":"10.1016\/j.ejpb.2024.114351_b0040","doi-asserted-by":"crossref","first-page":"e922","DOI":"10.1111\/aos.14708","article-title":"Causes of corneal transplant failure: a multicentric study","volume":"99","author":"G\u00f3mez-Benlloch","year":"2021","journal-title":"Acta Ophthalmol."},{"key":"10.1016\/j.ejpb.2024.114351_b0045","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1097\/ICO.0000000000000258","article-title":"Efficacy and safety of systemic tacrolimus in high-risk penetrating keratoplasty after graft failure with systemic cyclosporine","volume":"33","author":"Yamazoe","year":"2014","journal-title":"Cornea"},{"key":"10.1016\/j.ejpb.2024.114351_b0050","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.ajo.2010.03.010","article-title":"Sirolimus and mycophenolate as combination prophylaxis in corneal transplant recipients at high rejection risk","volume":"150","author":"Chatel","year":"2010","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.ejpb.2024.114351_b0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.cclet.2022.06.071","article-title":"Nanoparticle-mediated corneal neovascularization treatments: Toward new generation of drug delivery systems","volume":"34","author":"Zhu","year":"2023","journal-title":"Chin. Chem. Lett."},{"key":"10.1016\/j.ejpb.2024.114351_b0060","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1038\/s41433-019-0717-3","article-title":"Observation of topical tacrolimus on high-risk penetrating keratoplasty patients: a randomized clinical trial study","volume":"34","author":"Zhai","year":"2020","journal-title":"Eye"},{"key":"10.1016\/j.ejpb.2024.114351_b0065","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1097\/ICO.0000000000002709","article-title":"Efficacy of immunosuppressants in high rejection risk keratoplasty: a meta-analysis of comparative studies","volume":"40","author":"Yu","year":"2021","journal-title":"Cornea"},{"key":"10.1016\/j.ejpb.2024.114351_b0070","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1097\/ICO.0b013e31812f66e5","article-title":"Corneal transplant rejection rate and severity after endothelial keratoplasty","volume":"26","author":"Allan","year":"2007","journal-title":"Cornea"},{"key":"10.1016\/j.ejpb.2024.114351_b0075","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.ajo.2007.03.028","article-title":"Long-term topical steroid treatment improves graft survival following normal-risk penetrating keratoplasty","volume":"144","author":"Nguyen","year":"2007","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.ejpb.2024.114351_b0080","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1097\/ICO.0000000000000403","article-title":"Prevention and treatment of corneal graft rejection: current practice patterns of the Cornea Society (2011)","volume":"34","author":"Kharod-Dholakia","year":"2015","journal-title":"Cornea"},{"key":"10.1016\/j.ejpb.2024.114351_b0085","doi-asserted-by":"crossref","first-page":"eadf4608","DOI":"10.1126\/sciadv.adf4608","article-title":"Six-month effective treatment of corneal graft rejection","volume":"9","author":"Meng","year":"2023","journal-title":"Sci. Adv."},{"key":"10.1016\/j.ejpb.2024.114351_b0090","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s10792-015-0137-8","article-title":"Systemic cyclosporine and corneal transplantation","volume":"36","author":"Ziaei","year":"2016","journal-title":"Int. Ophthalmol."},{"key":"10.1016\/j.ejpb.2024.114351_b0095","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1038\/sj.eye.6700144","article-title":"Combined intravenous pulse methylprednisolone and oral cyclosporine A in the treatment of corneal graft rejection: 5-year experience","volume":"16","author":"Young","year":"2002","journal-title":"Eye"},{"key":"10.1016\/j.ejpb.2024.114351_b0100","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1097\/ICO.0000000000000291","article-title":"Topical cyclosporine in corneal transplantation","volume":"34","author":"Ziaei","year":"2015","journal-title":"Cornea"},{"key":"10.1016\/j.ejpb.2024.114351_b0105","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/s12886-022-02318-w","article-title":"Topical administration of tacrolimus and corticosteroids in tapering doses is effective in preventing immune rejection in high-risk keratoplasty: a 5-year follow-up study","volume":"22","author":"Qi","year":"2022","journal-title":"BMC Ophthalmol."},{"key":"10.1016\/j.ejpb.2024.114351_b0110","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.ijpharm.2007.07.045","article-title":"Preparation of rapamycin-loaded chitosan\/PLA nanoparticles for immunosuppression in corneal transplantation","volume":"349","author":"Yuan","year":"2008","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2024.114351_b0115","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1097\/00003226-200208000-00018","article-title":"Danger of systemic cyclosporine for corneal graft","volume":"21","author":"Algros","year":"2002","journal-title":"Cornea"},{"key":"10.1016\/j.ejpb.2024.114351_b0120","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1111\/ctr.12361","article-title":"The incidence, management, and evolution of rapamycin-related side effects in kidney transplant recipients","volume":"28","author":"Verhave","year":"2014","journal-title":"Clin. Transplant."},{"key":"10.1016\/j.ejpb.2024.114351_b0125","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1080\/17512433.2019.1675507","article-title":"Exploring the neuroregenerative potential of tacrolimus","volume":"12","author":"Saffari","year":"2019","journal-title":"Expert. Rev. Clin. Pharmacol."},{"key":"10.1016\/j.ejpb.2024.114351_b0130","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.jconrel.2015.01.009","article-title":"Corticosteroid-loaded biodegradable nanoparticles for prevention of corneal allograft rejection in rats","volume":"201","author":"Pan","year":"2015","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2024.114351_b0135","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.clim.2015.04.013","article-title":"Micro and nanoparticle drug delivery systems for preventing allotransplant rejection","volume":"160","author":"Fisher","year":"2015","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.ejpb.2024.114351_b0140","doi-asserted-by":"crossref","first-page":"3960","DOI":"10.1016\/j.biomaterials.2008.06.017","article-title":"PEG-stabilized carbodiimide crosslinked collagen\u2013chitosan hydrogels for corneal tissue engineering","volume":"29","author":"Rafat","year":"2008","journal-title":"Biomaterials"},{"key":"10.1016\/j.ejpb.2024.114351_b0145","doi-asserted-by":"crossref","first-page":"15346","DOI":"10.1073\/pnas.2536767100","article-title":"Cellular and nerve regeneration within a biosynthetic extracellular matrix for corneal transplantation","volume":"100","author":"Li","year":"2003","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.ejpb.2024.114351_b0150","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1080\/17425247.2020.1748006","article-title":"Application of PLGA nano\/microparticle delivery systems for immunomodulation and prevention of allotransplant rejection","volume":"17","author":"Keshavarz Shahbaz","year":"2020","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.ejpb.2024.114351_b0155","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.3389\/fimmu.2018.02283","article-title":"Rapamycin nano-micelle ophthalmic solution reduces corneal allograft rejection by potentiating myeloid-derived suppressor cells' function","volume":"9","author":"Wei","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ejpb.2024.114351_b0160","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/j.ajo.2006.06.051","article-title":"Microbial keratitis following corneal transplantation","volume":"142","author":"Wright","year":"2006","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.ejpb.2024.114351_b0165","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1111\/j.1442-9071.2007.01512.x","article-title":"Microbial keratitis following corneal transplantation","volume":"35","author":"Das","year":"2007","journal-title":"Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.ejpb.2024.114351_b0170","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1097\/ICO.0000000000002044","article-title":"Recurrence of infection in corneal grafts after therapeutic penetrating keratoplasty for microbial keratitis","volume":"39","author":"Chatterjee","year":"2020","journal-title":"Cornea"},{"key":"10.1016\/j.ejpb.2024.114351_b0175","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1016\/S0161-6420(88)33008-3","article-title":"Late bacterial and fungal keratitis after corneal transplantation: spectrum of pathogens, graft survival, and visual prognosis","volume":"95","author":"Harris","year":"1988","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ejpb.2024.114351_b0180","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.survophthal.2020.08.004","article-title":"Surgical alternatives to keratoplasty in microbial keratitis","volume":"66","author":"Singhal","year":"2021","journal-title":"Surv. Ophthalmol."},{"key":"10.1016\/j.ejpb.2024.114351_b0185","doi-asserted-by":"crossref","first-page":"3110","DOI":"10.1038\/s41433-020-01378-w","article-title":"Infectious keratitis: trends in microbiological and antibiotic sensitivity patterns","volume":"35","author":"Soleimani","year":"2021","journal-title":"Eye"},{"key":"10.1016\/j.ejpb.2024.114351_b0190","doi-asserted-by":"crossref","first-page":"1900001","DOI":"10.1002\/mabi.201900001","article-title":"Stimulus-responsive hydrogel for ophthalmic drug delivery","volume":"19","author":"Lin","year":"2019","journal-title":"Macromol. Biosci."},{"key":"10.1016\/j.ejpb.2024.114351_b0195","doi-asserted-by":"crossref","first-page":"2109173","DOI":"10.1002\/adfm.202109173","article-title":"Multifunctional supramolecular filament hydrogel boosts anti-inflammatory efficacy in vitro and in vivo","volume":"32","author":"Deng","year":"2022","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.ejpb.2024.114351_b0200","doi-asserted-by":"crossref","first-page":"3936","DOI":"10.1016\/j.cclet.2021.03.037","article-title":"Bioinspired self-assembly supramolecular hydrogel for ocular drug delivery","volume":"32","author":"Li","year":"2021","journal-title":"Chin. Chem. Lett."},{"key":"10.1016\/j.ejpb.2024.114351_b0205","first-page":"420","article-title":"Drug-peptide supramolecular hydrogel boosting transcorneal permeability and pharmacological activity via ligand-receptor interaction","volume":"10","author":"Chen","year":"2022","journal-title":"Bioact. Mater."},{"key":"10.1016\/j.ejpb.2024.114351_b0210","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.ejpb.2015.05.016","article-title":"Hydrogels in ophthalmic applications","volume":"95","author":"Kirchhof","year":"2015","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2024.114351_b0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.msec.2021.112212","article-title":"Hydrogels-based ophthalmic drug delivery systems for treatment of ocular diseases","volume":"127","author":"Fang","year":"2021","journal-title":"Mater Sci Eng C Mater Biol Appl"},{"key":"10.1016\/j.ejpb.2024.114351_b0220","doi-asserted-by":"crossref","first-page":"4321","DOI":"10.1016\/j.cclet.2022.01.024","article-title":"A novel corneal adhesive based on functionally coupled PEG-lysozyme hydrogel for wound closure after surgical eye surgery","volume":"33","author":"Zhang","year":"2022","journal-title":"Chin. Chem. Lett."},{"key":"10.1016\/j.ejpb.2024.114351_b0225","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1021\/acs.biomac.5b01526","article-title":"Fabrication of a micellar supramolecular hydrogel for ocular drug delivery","volume":"17","author":"Zhang","year":"2016","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.ejpb.2024.114351_b0230","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.ijpharm.2013.03.024","article-title":"Development and evaluation of fast forming nano-composite hydrogel for ocular delivery of diclofenac","volume":"448","author":"Li","year":"2013","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2024.114351_b0235","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.jconrel.2022.03.011","article-title":"Enzyme-instructed self-assembly of peptide-drug conjugates in tear fluids for ocular drug delivery","volume":"344","author":"Hu","year":"2022","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2024.114351_b0240","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.jconrel.2017.10.031","article-title":"Injectable hydrogels for ophthalmic applications","volume":"268","author":"Wang","year":"2017","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2024.114351_b0245","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jconrel.2019.05.034","article-title":"Hydrogel-based ocular drug delivery systems: Emerging fabrication strategies, applications, and bench-to-bedside manufacturing considerations","volume":"306","author":"Cooper","year":"2019","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2024.114351_b0250","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1016\/j.cclet.2021.12.093","article-title":"An injectable mPEG-PDLLA microsphere\/PDLLA-PEG-PDLLA hydrogel composite for soft tissue augmentation","volume":"33","author":"Pan","year":"2022","journal-title":"Chin. Chem. Lett."},{"key":"10.1016\/j.ejpb.2024.114351_b0255","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.actbio.2021.06.027","article-title":"Cationic self-assembled peptide-based molecular hydrogels for extended ocular drug delivery","volume":"131","author":"Liu","year":"2021","journal-title":"Acta Biomater."},{"key":"10.1016\/j.ejpb.2024.114351_b0260","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2023.123205","article-title":"Dissolvable hybrid microneedle patch for efficient delivery of curcumin to reduce intraocular inflammation","volume":"643","author":"Shi","year":"2023","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2024.114351_b0265","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2022.114756","article-title":"Development and evaluation of a new test kit for determination of immunosuppressants in blood by UHPLC-MS\/MS","volume":"215","author":"Wu","year":"2022","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.ejpb.2024.114351_b0270","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0378-5173(00)00617-7","article-title":"Solubilization of rapamycin","volume":"213","author":"Simamora","year":"2001","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2024.114351_b0275","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1097\/00003226-200009000-00008","article-title":"Twenty-five\u2013year panorama of corneal immunology: emerging concepts in the immunopathogenesis of microbial keratitis, peripheral ulcerative keratitis, and corneal transplant rejection","volume":"19","author":"Dana","year":"2000","journal-title":"Cornea"},{"key":"10.1016\/j.ejpb.2024.114351_b0280","doi-asserted-by":"crossref","first-page":"888","DOI":"10.3109\/08820139.2014.910024","article-title":"Immunological aspects of corneal transplant","volume":"43","author":"Kumar","year":"2014","journal-title":"Immunol. Invest."},{"key":"10.1016\/j.ejpb.2024.114351_b0285","doi-asserted-by":"crossref","first-page":"2468","DOI":"10.1097\/TP.0000000000002938","article-title":"High-risk corneal transplantation: recent developments and future possibilities","volume":"103","author":"Armitage","year":"2019","journal-title":"Transplantation"},{"key":"10.1016\/j.ejpb.2024.114351_b0290","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.cell.2012.03.017","article-title":"mTOR signaling in growth control and disease","volume":"149","author":"Laplante","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.ejpb.2024.114351_b0295","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.cmet.2014.01.001","article-title":"Rapamycin: one drug, many effects","volume":"19","author":"Li","year":"2014","journal-title":"Cell Metab."},{"key":"10.1016\/j.ejpb.2024.114351_b0300","doi-asserted-by":"crossref","first-page":"45117","DOI":"10.1074\/jbc.M303789200","article-title":"Phosphatidic acid regulates systemic inflammatory responses by modulating the Akt-mammalian target of rapamycin-p70 S6 kinase 1 pathway","volume":"278","author":"Lim","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejpb.2024.114351_b0305","first-page":"281","article-title":"Macrophages in inflammation, Curr Drug Targets Inflamm","volume":"4","author":"Fujiwara","year":"2005","journal-title":"Allergy"},{"key":"10.1016\/j.ejpb.2024.114351_b0310","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1002\/ptr.4838","article-title":"Antipyretic and anti-inflammatory effects of asiaticoside in lipopolysaccharide-treated rat through up-regulation of heme oxygenase-1","volume":"27","author":"Wan","year":"2013","journal-title":"Phytother. Res."},{"key":"10.1016\/j.ejpb.2024.114351_b0315","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2020.155148","article-title":"Anti-inflammatory effects of adiponectin in cigarette smoke-activated alveolar macrophage through the COX-2\/PGE2 and TLRs signaling pathway","volume":"133","author":"Wang","year":"2020","journal-title":"Cytokine"},{"key":"10.1016\/j.ejpb.2024.114351_b0320","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2022.121755","article-title":"The topical ocular delivery of rapamycin to posterior eye tissues and the suppression of retinal inflammatory disease","volume":"621","author":"Badr","year":"2022","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2024.114351_b0325","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1089\/jop.2023.0035","article-title":"Pharmacokinetics of sirolimus eye drops following topical ocular administration in rabbits","volume":"39","author":"Lin","year":"2023","journal-title":"J. Ocul. Pharmacol. Ther."}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641124001772?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641124001772?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,17]],"date-time":"2024-10-17T13:52:24Z","timestamp":1729173144000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939641124001772"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":65,"alternative-id":["S0939641124001772"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2024.114351","relation":{},"ISSN":["0939-6411"],"issn-type":[{"value":"0939-6411","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nanoparticle-hydrogel composite as dual-drug delivery system for the potential application of corneal graft rejection","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutics and Biopharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpb.2024.114351","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"114351"}}